A report detailing the most striking differences in reporting between your product and a competitor can be generated. It can highlight differences not especially captured within the label of the product or consequently not integrated in the benefit-risk.
As an example, differences in the medication errors could convince national authorities to favour one product over the other.
If you want to have more details about the theory behind it, a poster was presented at the yearly conference of the International Society of Pharmacovigilance (ISoP) in Verona. Poster_QR_OSPV.pdf